Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Evaluation of FDG PET combined with cardiac MRI for the diagnosis and therapeutic monitoring of cardiac sarcoidosis.

Sgard B, Brillet PY, Bouvry D, Djelbani S, Nunes H, Meune C, Valeyre D, Soussan M.

Clin Radiol. 2018 Oct 25. pii: S0009-9260(18)30552-X. doi: 10.1016/j.crad.2018.09.015. [Epub ahead of print]

PMID:
30482560
2.

[Pulmonary tuberculosis: Radiological evolution of broncho-pulmonary lesions at the end of treatment].

Méchaï F, Fock-Yee C, Bouvry D, Raffetin A, Bouchaud O, Brauner M, Brillet PY.

Rev Mal Respir. 2018 Sep 17. pii: S0761-8425(18)30267-5. doi: 10.1016/j.rmr.2018.08.005. [Epub ahead of print] French.

PMID:
30236440
3.

G908R NOD2 variant in a family with sarcoidosis.

Besnard V, Calender A, Bouvry D, Pacheco Y, Chapelon-Abric C, Jeny F, Nunes H, Planès C, Valeyre D.

Respir Res. 2018 Mar 20;19(1):44. doi: 10.1186/s12931-018-0748-5.

4.

The Lung in Dysregulated States of Humoral Immunity.

Uzunhan Y, Jeny F, Kambouchner M, Didier M, Bouvry D, Nunes H, Bernaudin JF, Valeyre D.

Respiration. 2017;94(5):389-404. doi: 10.1159/000480297. Epub 2017 Sep 15. Review.

5.

Chronic pulmonary aspergillosis complicating sarcoidosis.

Uzunhan Y, Nunes H, Jeny F, Lacroix M, Brun S, Brillet PY, Martinod E, Carette MF, Bouvry D, Charlier C, Lanternier F, Planès C, Tazi A, Lortholary O, Baughman RP, Valeyre D.

Eur Respir J. 2017 Jun 15;49(6). pii: 1602396. doi: 10.1183/13993003.02396-2016. Print 2017 Jun.

6.

Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.

Heidelberger V, Ingen-Housz-Oro S, Marquet A, Mahevas M, Bessis D, Bouillet L, Caux F, Chapelon-Abric C, Debarbieux S, Delaporte E, Duval-Modeste AB, Fain O, Joly P, Marchand-Adam S, Monfort JB, Noël N, Passeron T, Ruivard M, Sarrot-Reynauld F, Verrot D, Bouvry D, Fardet L, Chosidow O, Sève P, Valeyre D.

JAMA Dermatol. 2017 Jul 1;153(7):681-685. doi: 10.1001/jamadermatol.2017.1162.

7.

Pleuroparenchymal fibroelastosis associated with telomerase reverse transcriptase mutations.

Nunes H, Jeny F, Bouvry D, Picard C, Bernaudin JF, Ménard C, Brillet PY, Kannengiesser C, Valeyre D, Kambouchner M.

Eur Respir J. 2017 May 11;49(5). pii: 1602022. doi: 10.1183/13993003.02022-2016. Print 2017 May. No abstract available.

8.

Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients.

Jamilloux Y, Cohen-Aubart F, Chapelon-Abric C, Maucort-Boulch D, Marquet A, Pérard L, Bouillet L, Deroux A, Abad S, Bielefeld P, Bouvry D, André M, Noel N, Bienvenu B, Proux A, Vukusic S, Bodaghi B, Sarrot-Reynauld F, Iwaz J, Amoura Z, Broussolle C, Cacoub P, Saadoun D, Valeyre D, Sève P; Groupe Sarcoïdose Francophone.

Semin Arthritis Rheum. 2017 Oct;47(2):288-294. doi: 10.1016/j.semarthrit.2017.03.005. Epub 2017 Mar 8.

PMID:
28392046
9.

Long-term outcomes of refractory neurosarcoidosis treated with infliximab.

Cohen Aubart F, Bouvry D, Galanaud D, Dehais C, Mathey G, Psimaras D, Haroche J, Pottier C, Hie M, Mathian A, Devilliers H, Nunes H, Valeyre D, Amoura Z.

J Neurol. 2017 May;264(5):891-897. doi: 10.1007/s00415-017-8444-9. Epub 2017 Mar 4.

PMID:
28260120
10.

Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.

Pacheco Y, Calender A, Israël-Biet D, Roy P, Lebecque S, Cottin V, Bouvry D, Nunes H, Sève P, Pérard L, Devouassoux G, Freymond N, Khouatra C, Wallaert B, Lamy R, Elsensohn MH, Bardel C, Valeyre D; GSF group.

Orphanet J Rare Dis. 2016 Dec 3;11(1):165.

11.

Treatment of neurosarcoidosis: A comparative study of methotrexate and mycophenolate mofetil.

Bitoun S, Bouvry D, Borie R, Mahevas M, Sacre K, Haroche J, Psimaras D, Pottier C, Mathian A, Hie M, Boutin DL, Papo T, Godeau B, Valeyre D, Nunes H, Amoura Z, Cohen Aubart F.

Neurology. 2016 Dec 13;87(24):2517-2521. Epub 2016 Nov 16.

PMID:
27856779
12.

Management of sarcoidosis in clinical practice.

Jeny F, Bouvry D, Freynet O, Soussan M, Brauner M, Planes C, Nunes H, Valeyre D.

Eur Respir Rev. 2016 Jun;25(140):141-50. doi: 10.1183/16000617.0013-2016. Review.

13.

Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans.

Miyara M, Chader D, Sage E, Sugiyama D, Nishikawa H, Bouvry D, Claër L, Hingorani R, Balderas R, Rohrer J, Warner N, Chapelier A, Valeyre D, Kannagi R, Sakaguchi S, Amoura Z, Gorochov G.

Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7225-30. doi: 10.1073/pnas.1508224112. Epub 2015 May 26.

14.

Perception of lung cancer among the general population and comparison with other cancers.

Mazières J, Pujol JL, Kalampalikis N, Bouvry D, Quoix E, Filleron T, Targowla N, Jodelet D, Milia J, Milleron B.

J Thorac Oncol. 2015 Mar;10(3):420-5. doi: 10.1097/JTO.0000000000000433.

15.

Progressive multifocal leukoencephalopathy in patients with sarcoidosis.

Jamilloux Y, Néel A, Lecouffe-Desprets M, Fèvre A, Kerever S, Guillon B, Bouvry D, Varron L, Redares C, Dominique S, Roux M, Chapelon-Abric C, Valeyre D, Ducray F, Bernard C, Broussolle C, Hamidou M, Sève P.

Neurology. 2014 Apr 15;82(15):1307-13. doi: 10.1212/WNL.0000000000000318. Epub 2014 Mar 7.

PMID:
24610328
16.

Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID.

Naccache JM, Bouvry D, Valeyre D.

Eur Respir J. 2014 Mar;43(3):924-5. doi: 10.1183/09031936.00170013. No abstract available.

17.

Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers.

Bloom CI, Graham CM, Berry MP, Rozakeas F, Redford PS, Wang Y, Xu Z, Wilkinson KA, Wilkinson RJ, Kendrick Y, Devouassoux G, Ferry T, Miyara M, Bouvry D, Valeyre D, Gorochov G, Blankenship D, Saadatian M, Vanhems P, Beynon H, Vancheeswaran R, Wickremasinghe M, Chaussabel D, Banchereau J, Pascual V, Ho LP, Lipman M, O'Garra A.

PLoS One. 2013 Aug 5;8(8):e70630. doi: 10.1371/journal.pone.0070630. Print 2013. Erratum in: PLoS One. 2013;8(8).doi: 10.1371/annotation/7d9ec449-aee0-48fe-8111-0c110850c0c1. Dominique, Valeyre [corrected to Valeyre, Dominique].

18.

Granulomatosis-associated common variable immunodeficiency disorder: a case-control study versus sarcoidosis.

Bouvry D, Mouthon L, Brillet PY, Kambouchner M, Ducroix JP, Cottin V, Haroche J, Viallard JF, Lazor R, Lebargy F, Tazi A, Wallaert B, Smail A, Pellegrin JL, Nunes H, Amoura Z, Cordier JF, Valeyre D, Naccache JM; Groupe Sarcoïdose Francophone.

Eur Respir J. 2013 Jan;41(1):115-22. doi: 10.1183/09031936.00189011. Epub 2012 Aug 16.

19.

[Surgical lung biopsy: Indications and therapeutic implications].

Radu DM, Macey J, Bouvry D, Seguin A, Valeyre D, Martinod E.

Rev Pneumol Clin. 2012 Apr;68(2):161-9. doi: 10.1016/j.pneumo.2012.01.011. Epub 2012 Mar 16. Review. French.

PMID:
22425502
20.

Acute exacerbation of idiopathic pulmonary fibrosis: outcome and prognostic factors.

Simon-Blancal V, Freynet O, Nunes H, Bouvry D, Naggara N, Brillet PY, Denis D, Cohen Y, Vincent F, Valeyre D, Naccache JM.

Respiration. 2012;83(1):28-35. doi: 10.1159/000329891. Epub 2011 Aug 23.

21.

[Epidemiology of interstitial lung diseases].

Valeyre D, Freynet O, Dion G, Bouvry D, Annesi-Maesano I, Nunes H.

Presse Med. 2010 Jan;39(1):53-9. doi: 10.1016/j.lpm.2009.09.015. Epub 2009 Dec 4. French.

PMID:
19962852
22.

[Thoracic sarcoidosis].

Nunes H, Uzunhan Y, Freynet O, Naccache JM, Bouvry D, Brillet PY, Valeyre D.

Presse Med. 2010 Jan;39(1):93-106. doi: 10.1016/j.lpm.2009.10.010. Epub 2009 Dec 2. French.

PMID:
19959325
23.

[Atypical progressive multifocal leukoencephalopathy (PML) in a patient with pulmonary sarcoidosis].

Le Guilloux J, Roubiou C, Mallet J, Bouvry D, Alkhalil A, Coman I, Belin C, Gorochov G, Carpentier A, Mokhtari K, Carpentier AF.

Rev Neurol (Paris). 2010 Mar;166(3):341-5. doi: 10.1016/j.neurol.2009.05.015. Epub 2009 Jul 8. French.

PMID:
19589551
24.

[Respiratory rehabilitation in idiopathic pulmonary fibrosis: awaiting new studies, some encouraging results].

Naccache JM, Bouvry D.

Rev Mal Respir. 2009 Mar;26(3):253-4. French. No abstract available.

PMID:
19367197
25.

Up-to-date in pulmonary and extrapulmonary sarcoidosis.

Valeyre D, Uzunhan Y, Bouvry D, Naccache JM, Nunes H.

Acta Clin Belg. 2008 Nov-Dec;63(6):408-13. Review.

PMID:
19170359
26.

[Diagnostic challenges in sarcoidosis].

Bouvry D, Carton Z, Nunes H.

Rev Prat. 2008 May 31;58(10):1095-7. French.

PMID:
18652409
27.

[Natural history of sarcoidosis].

Valeyre D, Bouvry D, Uzunhan Y, Naccache JM, Brauner M, Nunes H.

Rev Prat. 2008 May 31;58(10):1091-4. French.

PMID:
18652408
28.

[Interstitial lung diseases in sarcoidosis].

Bouvry D, Naccache JM, Valeyre D.

Rev Prat. 2007 Dec 31;57(20):2258-65. Review. French.

PMID:
18320746
29.

[Atypical sarcoidosis].

Bouvry D, Uzunhan Y, Naccache JM, Nunes H, Brillet PY, Valeyre D.

Rev Med Interne. 2008 Jan;29(1):46-53. Epub 2007 Oct 30. Review. French.

PMID:
18054125
30.

Sarcoidosis.

Nunes H, Bouvry D, Soler P, Valeyre D.

Orphanet J Rare Dis. 2007 Nov 19;2:46. Review.

31.

Severe Actinobacillus ureae meningitis in an immunocompromised patient: report of one case and review of the literature.

de Castro N, Pavie J, Lagrange-Xélot M, Bouvry D, Delisle F, Parrot A, Molina JM.

Scand J Infect Dis. 2007;39(11-12):1076-9. Epub 2007 Aug 6. Review.

PMID:
17852903
32.

Hypoxia-induced cytoskeleton disruption in alveolar epithelial cells.

Bouvry D, Planès C, Malbert-Colas L, Escabasse V, Clerici C.

Am J Respir Cell Mol Biol. 2006 Nov;35(5):519-27. Epub 2006 Jun 1.

PMID:
16741163
33.

Accuracy of delayed (24 hours) processing of bronchoalveolar lavage for diagnosing bacterial pneumonia.

de Lassence A, Joly-Guillou ML, Salah A, Martin-Lefevre L, Hidri N, Ricard JD, Bouvry D, de Castro N, Dreyfuss D.

Crit Care Med. 2004 Mar;32(3):680-5.

PMID:
15090947
34.

[Respiratory manifestations of common variable immunodeficiency in adults].

Cadranel J, Bouvry D, Wislez M.

Rev Mal Respir. 2003 Feb;20(1 Pt 1):126-33. Review. French.

PMID:
12709641

Supplemental Content

Loading ...
Support Center